The use of contrasted transvaginal sonography in the diagnosis of gynecologic diseases: A preliminary study

Journal of Ultrasound in Medicine

Volumn 24, Issue 9, 2005, Pages 1267-1278

  Testa, Antonia Carla ^a   Ferrandina, Gabriella ^a   Fruscella, Erika ^a   Van Holsbeke, Caroline ^b   Ferrazzi, Enrico ^c   Leone, Francesco P G ^c   Arduini, Domenico ^d   Exacoustos, Caterina ^d   Bokor, Daniela ^e   Scambia, Giovanni ^f   Timmerman, Dirk ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e Bracco Imaging SpA   (Italy)

^f CATHOLIC UNIVERSITY   (Italy)

Author keywords

Contrast media; Endovaginal probe; Gynecology; Sonography

Indexed keywords

CONTRAST MEDIA; DISEASES; DOPPLER EFFECT; IMAGING SYSTEMS; PROBES; TISSUE; TISSUE CULTURE; TUMORS;

CONTRAST-TUNED IMAGING (CNTI); ENDOVAGINAL PROBE; SONOGRAPHY; ULTRASOUND TECHNOLOGY;

ULTRASONICS;

CONTRAST MEDIUM; SONOVUE;

ADNEXA DISEASE; ADOLESCENT; ADULT; AGED; ARTICLE; B SCAN; BENIGN TUMOR; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; FEMALE; FEMALE GENITAL TRACT TUMOR; GYNECOLOGIC DISEASE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MECHANICAL PROBE; MICROVASCULATURE; PELVIS TUMOR; TECHNOLOGY; TRANSVAGINAL ECHOGRAPHY; UTERINE CERVIX CANCER; UTERINE CERVIX TUMOR; UTERUS DISEASE;

EID: 24144475891     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2005.24.9.1267     Document Type: Article

References (9)

1. Tekay A, Jouppila R Validity of pulsatility and resistance indices in classification of adnexal tumors with transvaginal color Doppler ultrasound. Ultrasound Obstet Gynecol 1992; 2:338-344.
2. Gorce J-M, Arditi M, Schneider M. Influence of bubble size distribution on the echogenicity of ultrasound contrast agents: a study of SonoVue. Invest Radiol 2000; 35:661-671.
3. Cotter B, Mahamud E, Kwan OL, DeMaria AN. New ultrasound contrast agents: expanding upon existing clinical applications. In: Goldberg B (ed). Ultrasound Contrast Agents. London, England: Martin Dunitz Ltd; 1997:32-41.
4. Morel DR, Schwieger I, Hohn L, et al. Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest Radiol 2000; 35:80-85.
5. Bokor D, Chambers JB, Rees PJ, Mant TGK, Luzzani F, Spinazzi A. Clinical safety of SonoVue, a new contrast agent for ultrasound imaging, in healthy volunteers and in patients with chronic obstructive pulmonary disease. Invest Radiol 2001; 36:104-109.
6. Leen E, Angerson WJ, Yarmwnitis S, et al. Multicentre clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. Eur J Radiol 2002; 41:200-206.
7. Madjar H, Prompeler HJ, Del Bavero C, Hackeloer BJ, LIuII JB. A new Doppler signal enhancing agent for flow assessment in breast lesions. Eur J Ultrasound 2000; 12:123-130.
8. Nanda NC, Wistran DC, Karlsberg RP, et al. Multicenter evaluation of SonoVue for improved endocardial border delineation. Echocardiography 2002; 19:27-36.
9. Orden MR, Jurvelin JS, Kirkinen PP. Kinetics of a US contrast agent in benign and malignant adnexal tumors. Radiology 2003; 226:405-410.